QDEL (QDEL) Stock Price & Analysis
QDEL (QDEL) rose 0.29% to USD 13.97 as of September 8, 2026 at 07:34 UTC, according to Nexqual real-time market data.
QDEL last closed at USD 13.97; the session ranged USD 13.51–14.3 on volume of 890,257 shares. Market capitalization is —, with a 52-week range of USD 9.92–35.58 (NMS). Source: Nexqual, September 8, 2026 at 07:34 UTC.
Key Statistics (as of September 8, 2026 at 07:34 UTC)
| Price | USD 13.97 |
|---|---|
| Change | ▲ 0.29% (up) |
| Previous Close | USD 13.97 |
| Open | USD 13.97 |
| Day Range | USD 13.51 – 14.3 |
| 52-Week Range | USD 9.92 – 35.58 |
| Volume | 890,257 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (QDEL)
Nexqual's technical model rates QDEL "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 07:34 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 42.85 (neutral) |
| vs SMA50 | Below (USD 15.97) |
| MACD | -0.43 (negative) |
From QDEL's Latest SEC 10-K Filing (filed 2026-02-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RGEN | Repligen Corporation | USD 167.6 | ▼ 3.09% |
| FLGT | Fulgent Genetics, Inc. | USD 19.73 | ▼ 1.55% |
| NVCR | NovoCure Limited | USD 17.94 | ▲ 0.62% |
| DXCM | DexCom, Inc. | USD 87.9 | ▼ 2% |
| EBS | Emergent BioSolutions Inc. | USD 6.21 | ▼ 3.87% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:34 UTC. This page is informational and not investment advice.